We are live on ! Find out more
TFCP

Twin Focus Capital Partners Portfolio holdings

AUM $983M
1-Year Est. Return 37.07%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+37.07%
3 Year Est. Return
+92.46%
5 Year Est. Return
+88%
10 Year Est. Return
+241.11%
AUM
$101M
AUM Growth
-$3.65M
Cap. Flow
-$6.62M
Cap. Flow %
-6.53%
Top 10 Hldgs %
66.37%
Holding
94
New
14
Increased
15
Reduced
29
Closed
12

Top Buys

Rank Stock Value
1
PCRX icon
Pacira BioSciences
PCRX
+$525K
2
GE icon
GE Aerospace
GE
+$351K
3
ICE icon
Intercontinental Exchange
ICE
+$328K
4
DIS icon
Walt Disney
DIS
+$279K
5
AAPL icon
Apple
AAPL
+$274K

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$3.77M
2
GALT icon
Galectin Therapeutics
GALT
+$1.07M
3
TGNA
TEGNA Inc
TGNA
+$839K
4
NYX
NYSE EURONEXT INC
NYX
+$729K
5
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$471K

Sector Composition

Rank Sector Weight
1 Communication Services 19.3%
2 Energy 5.38%
3 Healthcare 3.58%
4 Financials 2.86%
5 Industrials 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SU icon
76
Suncor Energy
SU
$74.9B
$204K 0.2%
5,830
-275
-5% -$9.67K
WFM
77
DELISTED
Whole Foods Market Inc
WFM
$203K 0.2%
+3,504
New +$208K
LBF
78
DELISTED
Deutsche Global High Incm Fund
LBF
$160K 0.16%
20,000
– –
PMM
79
Franklin Managed Municipal Income Trust
PMM
$269M
$159K 0.16%
23,993
– –
KOG
80
DELISTED
KODIAK OIL & GAS CORP
KOG
$135K 0.13%
+12,000
New +$144K
NRK icon
81
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$903M
$126K 0.12%
10,233
– –
ALU
82
DELISTED
Alcatel-Lucent
ALU
$44K 0.04%
10,085
-403
-4% -$1.58K
BCS icon
83
Barclays
BCS
$96.2B
– –
-23,680
Closed -$81K
BTI icon
84
British American Tobacco
BTI
$128B
– –
-4,650
Closed -$244K
F icon
85
CALL
Ford
F
$56.9B
– –
-135,000
Closed -$253K
GALT icon
86
Galectin Therapeutics
GALT
$199M
– –
-107,363
Closed -$1.07M
IBM icon
87
IBM
IBM
$224B
– –
-1,517
Closed -$269K
VALE icon
88
Vale
VALE
$63.4B
– –
-11,445
Closed -$179K
VOO icon
89
Vanguard S&P 500 ETF
VOO
$1.01T
– –
-2,468
Closed -$380K
GAP
90
The Gap Inc
GAP
$7.41B
– –
-5,000
Closed -$201K
NE
91
DELISTED
Noble Corporation
NE
– –
-7,756
Closed -$256K
WFT
92
DELISTED
Weatherford International plc
WFT
– –
-10,310
Closed -$158K
FRX
93
DELISTED
FOREST LABORATORIES INC
FRX
– –
-6,000
Closed -$257K
NYX
94
DELISTED
NYSE EURONEXT INC
NYX
– –
-17,360
Closed -$729K
1 2 3
4

Similar funds

PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
FFS
Forge Financial Services Edmond, Oklahoma $987M AUM 14.12% 1-Year Est. Return
PCM
Polymer Capital Management New York $988M AUM 56.33% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Twin Focus Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Twin Focus Capital Partners held 94 positions worth $101M, down 3.5% from $105M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Twin Focus Capital Partners withdrew a net $6.62M in Q4 2013, closing 12 positions and reducing 29 holdings. Its most notable exit was Galectin Therapeutics, an estimated $1.07M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 17% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Twin Focus Capital Partners opened a new position in Pacira BioSciences worth $574K.

  • Twin Focus Capital Partners's largest Q4 2013 buy was Pacira BioSciences: 9,981 shares worth $574K.
  • Twin Focus Capital Partners added most to GE Aerospace in Q4 2013, an estimated $351K increase.
  • Twin Focus Capital Partners's biggest Q4 2013 reduction was SPDR Gold Trust, cutting an estimated $3.77M.
  • Twin Focus Capital Partners fully exited Galectin Therapeutics in Q4 2013, selling an estimated $1.07M.
  • Twin Focus Capital Partners's ten largest holdings make up 66% of its $101M portfolio in Q4 2013.
  • Twin Focus Capital Partners opened 14 new positions and closed 12 in Q4 2013.
  • Twin Focus Capital Partners's portfolio value fell 3.5% quarter-over-quarter to $101M.

Based on Twin Focus Capital Partners's 13F filing for Q4 2013, filed 18 Feb 2014.